University of Nebraska Medical Center- Infectious Diseases — Omaha, Nebraska

University of Nebraska Medical Center- Infectious Diseases is a clinical research site located in Omaha, Nebraska, United States 68198-5400.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Nebraska Medical Center- Infectious Diseases has participated in 9 clinical trials.

Therapeutic areas: COVID-19, Staphylococcal Bacteraemia, Gastroenteritis Norovirus.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Omaha

Browse all research sites in Nebraska · View every site in Omaha

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Nebraska Medical Center- Infectious Diseases?

University of Nebraska Medical Center- Infectious Diseases has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Nebraska Medical Center- Infectious Diseases conducted?

University of Nebraska Medical Center- Infectious Diseases has 9 clinical trials on record. Their work covers COVID-19, Staphylococcal Bacteraemia, Gastroenteritis Norovirus.

Is University of Nebraska Medical Center- Infectious Diseases accredited by Crixeo Clinical Trials?

University of Nebraska Medical Center- Infectious Diseases has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Nebraska Medical Center- Infectious Diseases?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.